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Summary.-The present finding that mice metabolize a greater proportion of an
oral dose (50 mg/kg) of vinylidene chloride. (1,1-dichloroethylene, DCE) than rats
implies (a) that the efficiency of DCE metabolism follows the known activity of
cytochrome P-450 in the organs ofthese animals, and (b) that, in accordance with the
LD50 values, the real exposure (expressed as the amount of DCE metabolized) is
relatively higher for orally dosed mice than rats, and (c) that DCE carcinogenicity
would appear to be more likely in mice than rats.
Mice metabolize DCEsimilarlytorats (JonesandHathway, 1977)butthere are some
differences. Thus, qualitatively, treated mice (but not rats) excrete a small amount of
N-acetyl-S-(2-carboxymethyl)cysteine. Quantitatively, (i) the relative proportions of
the N-acetyl-S-cysteinyl acetyl derivative that are formed in mice and rats parallel
the activity of liver glutathione-S-epoxide transferase in these rodents, and (ii) there
are marked differences in the proportions of DCE metabolites belonging to the
chloroacetic acid branch of the metabolic pathway. Furthermore, the previously
assumed ,B-thionase hydrolysis of thiodiglycollic acid (Jones and Hathway, 1977) is
now established in vivo, and the possible biogenesis of the N-acetyl-S-cysteinyl
acetyl derivative is verified by another tracer study. The conclusion is drawn that the
DCE metabolites, 1,1 -dichloroethylene oxide and chloroacetyl chloride, may be
important to murine DCE carcinogenicity.
WIDESPREAD use of the polymer of
vinylidene chloride* (1,1-dichloroethylene,
DCE) for packaging film and for coating
other packaging materials, and the recent
discovery of DCE tumorigenicity in the
kidneys of mice (Maltoni et al., 1977) but
not in rats, warrants a systematic search
for possible species differences in DCE
metabolism which might account for the
species susceptibility observed.
Previous work (Jones and Hathway,
1977; Walker and Hathway, 1977) on the
metabolism of DCE (Fig. 1(a)) in rats
showed that:
(i) thiodiglycollic acid (g) and an
N-acetyl-S-cysteinyl acetyl derivative
(e) (where R is considered to be OH and R'
is unknown) where the major urinary
metabolites associated with substantial
amounts of chloroacetic acid (b) dithiogly-
collic acid (j) and thioglycollic acid (h),
(ii) chloroacetic acid (b) a key metabolite
of DOE (a) biotransformation, afforded
in vivo several metabolites in common
with DCE, and
(iii) transformation of DCE (a) into
chloroacetic acid (b) involved migration
of one C1 atom and the loss of the other
one.
The experimental evidence implied that
the N-acetyl-S-cysteinyl acetyl derivative
(e) arises through the reaction of 1,1-
dichloroethylene oxide with glutathione,
a reaction catalysed by glutathione S-
epoxide transferase.
The present paper describes the results
of an investigation of DCE metabolism in
mice vis-a-vis the previous one in rats
* Known commercially as VDC.B. K. JONES AND D. E. HATHWAY
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FIG. 1.-Metabolic pathway for vinylidene chloride in mammals (see Introductory Section,
for the key to this scheme).
(Jones and Hathway, 1977) and attempts
to relate differences to the susceptibility
of the mouse to DCE.
MATERIALS AND METHODS
Chemicals.-Vinylidene chloride was sup-
plied by Imperial Chemical Industries
Limited, Mond Division, Runcorn, Cheshire.
Before each experiment, stabilizer was re-
moved by washing with alkali and water.
[1-14C]DCE and [2-14C)DCE with sp. act.
1-0 mCi/mmol, and with a chemical and
radiochemical purity >99-0%, were synthes-
ized from 14CO2 by our colleagues Mr D. C.
Greenslade and Dr J. A. Heslop of Imperial
Chemical Industries Limited, Petrochemicals
Division, Billingham, Cleveland. Whereas in
the case of [1-14C]DCE, 14CO2 was converted
into [1-14C]acetic acid by the Grignard
reaction with methyl iodide, in that of
[2-14C]DCE, 14CO2 was reduced to [14C]- methanol, which was transformed by a
reaction sequence involving [14C]methyl iodide and [2-14C]acetonitrile into [2-14C]- acetic acid. [1-14C] and [2-14C]acetic acids
respectively were then transformed through the variously labelled forms of the reaction
sequence, dichloroacetic acid, 2,2-dichloro-
ethanol and 1,1,2-trichloroethane, into the
V
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pure liquids [1-14C]DCE and [2-14C]DCE,
b.p. 37TC, which were stabilized by addition
of 10 parts/106 of hydroquinone. (1,2-Elimi-
nation of 1,1,2-trichloroethane was specific,
and gave DCE exclusively, but the attempted
1,2-elimination of 2,2-dichloroethanol fur-
nished intractable polymer.) Because of the
risk of polymerization, it was convenient to
store [14C]DCE as a solution in peroxide-free
corn oil at -20°C.
[1-14C]Chloroacetic acid with sp. act.
24 mCi/mmol, and [2-14C]chloroacetic acid
with sp. act. 24 mCi/mmol were obtained
from the Radiochemical Centre, Amersham,
Bucks.
L-S-(2-Carboxymethyl)[14C]cysteine with
sp. act. 0 1 mCi/mmol was prepared (Michae-
lis and Schubert, 1934) from chloroacetic acid
plus L-[U-14C]cysteine hydrochloride, with
sp. act. 24.5 mCi/mmol, and the structure
of the crystalline product, m.p. 175-176°C,
decomp., was confirmed by mass spectro-
metry.
[carboxy-14C]Thiodiglycollic acid with sp.
act. 210 ,uCi/mmol was prepared in aqueous
solution, overnight under N2, from [1-14C]-
chloroacetic acid, with sp. act. 24 mCi/mmol,
and Na2S in the molar proportions 2 :1
(cf. Loven, 1894). Pure [carboxy-14C]thiodi-
glycollic acid, m.p. 129°C, was extracted
with ether from the acidified mother liquor
and the structure was confirmed by mass
spectrometry.
Dithioglycollic acid (Aldrich Chemical Co.)
and thiodiglycollic acid, thioglycollic acid and
L-S-(2-carboxymethyl)cysteine (all 3 sub-
stances obtained from Sigma Chemical Co.)
were all of Grade 1 quality, with a purity
exceeding 99.5%.
All reagents and solvents were of AnalaR
grade or of the next highest quality avail-
able.
Experiments in animals.-Adult male rats
(Alderley Park strain (Wistar-derived), speci-
fic-pathogen-free) about 2 months old (200 g
body wt) and adult male mice (Alderley Park
strain, specific pathogen-free) about 5 weeks
old (25 g body wt) were used and kept on
standard pellet diet.
(a) For excretion-retention experiments,
groups of 6 mice received single doses
of[1-14C]DCE (50 mg/kg; 2 ItCi/animal) as a corn-oil solution by the intra-
gastric route. Each group of 6 animals
was housed in a glass metabolism cage
for 72 h after dosing, and 14C was
measured in the urine, faeces and
exhaled air, which was drawn success-
ively through 1,1,2-trichloroethylene
at -70°C and CO2 absorbers.
For the identification of urinary metabo-
lites, intragastric administration was made;
(b) to 10 mice of [1-14C]DCE (50 mg/kg;
5 ,tCi/animal) in corn-oil solution,
(c) to 4rats, housedsinglyinglass metabo-
lism cages, of [1-14C]DCE (50mg/kg;
8 ,uCi) in corn-oil solution,
(d) and (e) to 6 mice, housed collectively in
a glass metabolism cage, of either
[1-14C] or [2-14C]chloroacetic acid
(100 mg/kg; 6 ,uCi) in aqueous solution,
(f) to 8 mice of [carboxy-14C]thiodigly,
collic acid (80 mg/kg; 0 3 juCi) in
aqueous solution, and
(g) to 2 rats, housed individually in glass
metabolism cages, of L-S-(2-carboxy-
methyl)[14C]cysteine (150 mg/kg; 3,tCi)
in aqueous solution.
(h) Each member of 5 groups of 6 mice
(of each sex) received single intra-
gastric doses of DCE in corn-oil solu-
tion, over a range of 5 different DCE
concentrations, and LD50 values were
calculated respectively for male and
female animalsfromThompson's (1947)
method of moving averages and inter-
polation.
Measurement of radioactivity.-An auto-
mated and computerized Intertechnique
Model SL30 Liquid Scintillation Spectro-
meter was used for measurement of 14C,
making use ofstandard channel-ratio quench-
correction curves. The liquid samples were
mixed with scintillator and radio-assayed
direct.
Analysis of urinary DCE constituents.
The systematic separation of the urinary
metabolites into fractions of chemically
similar substances, the resolution of these
fractions by tlc and gc methods, and the
detection and identification of constituents,
or their suitable derivatives, by gc-mass
spectrometry were implemented in the same
way as has been described previously
(Jones and Hathway, 1977).
RESULTS AND DISCUSSIONS
The most conspicuous result of a study
of the comparative metabolism of an oral
413B. K. JONES AND D. E. HATHWAY
TABLE I.-Relative Proportion of [14C]
Excretory Products after Oral Admini-
stration of 50 mg/kg of
Rodents (Observations
Dosing)
[140] Excretory products
Unchanged DCE pulmonary
C02 excretion
Chloroacetic acid
Thiodiglycollic acid
Thioglycollic acid
Dithioglycollic acid
Thioglycollyloxalic acid
N-Acetyl-S-cysteinyl acetyl
derivative
N-Acetyl-S-(2-carboxymethyl)
cysteine
Urea
[1-14C]DCE to
3 Days after
14C expressed
as % of dose
.
Mice* Rats*
6 28
3 3-5
0 1
3 22
5 3
23 5
3 2
50 28
4 0
3 3-5
* Alderley Park strains.
dose (50 mg/kg) of DCE in mice and rats
was the finding that pulmonary excretion
ofunchanged DCE account for 28% ofthe
dose in rats, but for only 6% in mice
(Table I). At this dose level, mice metabol-
ize a greater proportion of the adminis-
tered DCE than rats; more than 20%.
The efficiency of DOE metabolism thus
parallels the activity ofcytochrome P-450,
which is known (Litterst et al., 1975) to be
higher in the principal drug-metabolizing
organs, (kidneys, liver and lungs) of mice
than of rats, and this observation is
entirely consistent with a metabolic path-
way involving initial epoxidation of DCE
(Jones and Hathway, 1977); Hathway,
1977; Walker and Hathway, 1977). In the
case ofthese orally dosed animals, the real
exposure (expressed interms ofthe amount
of DCE metabolized) is relatively higher
TABLE II.-Oral Toxicity in Animals
DCE
(in corn-oil solution)
Chloroacetic acid
(in aqueous solution)
LD50 (mg/kg body wt)
Rats Mice
1550* ,3, 217 (201-235)**
l?, 194 (171-221)**
76t 255t(194-334)**
* Haley, 1975: Holtzmand and Y rats.
t Woodard et al., 1941: albino animals, pre-
dominantly rats, but and Y mice.
** Confidence limits (P = 0-05) in parentheses.
for mice than for rats, and this ranking,
therefore, agrees with the order of LD50
values which we have found; DCE is
considerably more toxic to mice than to
rats (Table II). It is concluded that this
difference in exposure to DCE after a
given dose contributes partly, if not
entirely, to the species difference in
toxicity between mice and rats. However,
the toxicities in the 2 species of animal of
chloroacetic acid, a key metabolite result-
ing from epoxidation of DCE and hydro-
lysis of the 1,1-dichloroethylene oxide
rearrangement product chloroacetyl
chloride (Fig. 1), are in the reverse order
ofthose for DCE itself. Thus, it is feasible
that the reactive DCE metabolites, 1,1-
dichloroethylene oxide and chloroacetyl
chloride (but not chloroacetic acid) may
be connected with DCE toxicity, which
affects the kidney and liver (Irish, 1963;
Prendergast et al., 1967) particularly of
mice. Examination of the pulmonary and
urinary DCE metabolites (Table I) shows
that this substance is metabolized in much
the same way (Fig. 1) in mice and rats,
but there are some species differences in
metabolism. A single qualitative differ-
ence is the urinary excretion of a small
amount of N-acetyl-S-(2-carboxymethyl)
cysteine, which is formed in mice (but not
in rats) from the major metabolite, the
N-acetyl-S-cysteinyl acetyl derivative.
The fact that considerably more of the
N-acetyl-S-cysteinyl acetyl derivative was
formed in mice than in rats (Table I) is the
main quantitative difference in DCE
metabolism between these rodent species.
As aresult ofprevious work, it is concluded
that the N-acetyl-S-cysteinyl acetyl deriv-
ative arose from the reaction of 1,1-
dichloroethylene oxide with glutathione,
catalysed by glutathione S-epoxide trans-
ferase (Jones and Hathway, 1977; Hath-
way, 1977) and it has now been found that
the relative proportions of the N-acetyl-
S-cysteinyl acetyl derivative that are
formed in mice and rats do in fact parallel
the activity of liver glutathione S-epoxide
transferase in these species (Hayakawa,
Lemahieu and Udenfriend, 1974). Hence,
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it would appear that greater production of
this DCE excretory product (Table I) in
mice than in rats is due to the higher
cytochrome P-450 activity in the drug-
metabolizing organs of mice (v. supra) and
to a potentially saturable chloroacetic acid
metabolism in (v. infra) coupled with the
correspondingly higher activity of gluta-
thione S-epoxide transferase for the more
available murine 1,1-dichloroethylene
oxide (see Fig. 1).
The fact that Yllner's (1971) mice
excreted 6-22% of a relatively high dose
of 2 mg of chloroacetic acid as unchanged
starting acid provides a clue to the
possibility that the mechanism for chloro-
acetic acid metabolism may be saturable
in these animals. Although this phenome-
non has not been encountered with the
Alderley Park animals, we have found
that (in mice) only 30-40% of a dose of
chloroacetic acid was excreted as thiodi-
glycollic acid, compared with the 90%
resulting from a comparable dose in rats.
(Most ofthe remainder ofthe dose in both
species was accountable as N-acetyl-S-
(2-carboxymethyl)cysteine.)
Out of some 34% of the dose (of DCE)
that must have been transformed into
thiodiglycollic acid in mice, 5% was
excreted as thioglycollic acid (h) 23% as
dithioglycollic acid (j) and 3% as thiogly-
collyloxalic acid, compared with a very
much smaller proportion of the resulting
thiodiglycollic acid that was transformed
into these metabolites in rats (Table I).
These findings are reconcilable with the
hydrolysis of thiodiglycollic acid by /-
thionase (Michaelis and Schubert, 1934)
particularly in mice.
Our previous assumption that the
thioglycollic acid and dithioglycollic acid,
which were produced by DCE metabolism
in mammals, arose through /3-thionase
hydrolysis of the thiodiglycollic acid
metabolite (Jones and Hathway, 1977;
Hathway, 1977) has now been confirmed
in a tracer study with [carboxy-14C]
thiodiglycollic acid. Mice given 80 mg/kg
of this l4C-labelled compound afforded
-25% 3-thionase conversion. [14C] Thi-
oglycollic acid (6o% of the dose) and
[14C]dithioglycollic acid (9%0) were identi-
fied and measured in the urine, together
with 3%0 of a third 14C-labelled metabolite,
which had previously been identified in the
urine of [14C]DCE-treated rats as thiogly-
collyloxalic acid by mass spectrometry.
The mass spectrum ofthe dimethyl deriva-
tive (Table III) shows that the mass ion
TABLE III.-Mass Spectral Data for the
O-Di-methyl Derivative of Thioglycolly-
loxalic acid: CH30CH2. C. S. C.C02CH3
0 0
Ion
Molecular
M-CH30H
M -(CH30CH2 + H)
M -CO2CH3
M- CCH20CH3
M -CCO2CH3
0i
CH30CH2
m/e
192
160
146
133
119
52
61
75
28
50
105 28
45 100
(M= 192) loses a fragment, which may be
accounted for as (H3COCH2 + H), from
one end of the molecule, to give one of the
most conspicuous ions (M - 46). Out of
the methylated derivatives of the possible
structures which can be written commenc-
ing with thiodiglycollic acid as starting
acid, only the dimethyl derivative of
thioglycollyloxalic acid actually fulfils this
exacting mass spectrometric requirement.
Thioglycollyloxalic acid is accordingly
considered to have been formed through
(w - 1) oxidation ofthe product resulting
from the esterification ofthioglycollic acid
by a reactive (CoA ester) form of glycollic
acid (Fig. 2).
Recent work in rats (Jones and Hath-
way, 1977; Hathway, 1977) implied that
the DCE-derived N-acetyl-S-cysteinyl
acetyl derivative must have originated
from the reaction of 1,1-dichloroethylene
oxide with glutathione S-epoxide trans-
ferase, since, for example, none of this
compound resulted from the metabolism
ofchloroacetic acid, itselfa key metabolite
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CH20H
CO2H
(-H20)
HOH2C-C-S-CH2CO2H)
+20)
Ilr|_ o
S(CH,CO, H)2
-thionase+ H20
HSCH2CO2H
+0)
HOH2C-C-S-C-CO2H (SCH2CO2H)2
0 0
FIG. 2. P-Thionase hydrolysis of thiodiglycollic acid and ensuing biotransformations.
of DCE. Another tracer study with L-S-
(2-carboxymethyl)[14C]cysteine has now
given 14CO2 (30% of the dose) and
[14C]thiodiglycollic acid as major metabo-
lites, and this result verifies the supposi-
tion about the formation of the N-acetyl-
S-cysteinyl acetyl derivative from an
earlier metabolite of DCE than chloro-
acetic acid, presumably 1,1-dichloroethy-
lene oxide.
The present work emphasizes that the
metabolic pathway (Fig. 1) which had
been tentatively proposed for DCE in
mammals (Jones and Hathway, 1977;
Hathway, 1977) does in fact operate for
mice and rats. One of the most important
differences between mice and rats is the
availability of 1,1-dichloroethylene oxide
and its rearrangement product, chloro-
acetyl chloride, due to increased cyto-
chrome P-450 activity in mice (v. supra)
and to a potentially saturable chloroacetic
acid metabolism in these animals. Whilst
the reactive metabolite, 1,1-dichloro-
ethylene oxide, is readily detoxified by
reaction with glutathione, catalysed by
glutathione S-epoxide transferase, and
such disposition accounts for much of its
generation, reaction ofthis active metabo-
lite and its rearrangement product with
DNA (Hathway, 1977) is likely to be more
significant in mice than in rats. This
"biochemical lesion" may in turn initiate
the carcinogenicity described (Maltoni
et at., 1977) for DCE in mice, but not in
rats. On the other hand, disposal of 1,1-
dichloroethylene oxide by epoxide hydra-
tase seems to be relatively unimportant in
mice and rats, in which the reaction
product in vivo, 002, is formed only in very
small amounts.
Additional work is necessary to deter-
mine the position of man in respect ofthe
various toxicities and oncogenic potentials
which have been found for DCE in experi-
ments with different species of animal.
GENERAL DISCUSSION AND CONCLUSIONS
The toxic and carcinogenic properties
of vinylidene chloride (DCE) merit dis-
cussion. Thus, when a single oral dose of
only 100 mg ofDCE/kg was given to mice,
some of the animals died from the effects
of DCE metabolism, whereas at lower
tolerated inhalational doses, they evinced
signs of hepatic and renal injury (Irish,
1963; Prendergast et al., 1967) and some
of them succumbed after long (52 weeks')
chronic exposure (at 25 parts/106) to an
unusual tumour of the kidneys, a kidney
adenocarcinoma (Maltoni et al., 1977).
DCE acted as a causative agent eliciting
toxic and carcinogenic effects in Maltoni's
(1977) Swiss mice; in this case, the toxic
and carcinogenic properties seem to be
antagonistic and complementary. This
observation is not altogether surprising,
because highly toxic substances would
be more likely to cause the necrosis of
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cells than to modify them biologically in
such a way as to ensure their survival and
ultimate transformation into irreversibly
tumorigenic ones. For example, whilst
benzene is highly toxic to blood-forming
tissue, it is a relatively mild leukaemic
agent, whereas 2-naphthylamine is only
slightly toxic to man, but is a powerful
frank carcinogen. Although an attempt has
been made to define the "biochemical
lesion" responsibleforDCE carcinogenicity
in mice (Hathway, 1977; Jones and
Hathway, 1977) and to describe the bio-
chemical mechanism for the acute toxicity
in rats (Jaeger et al., 1973, 1975) we feel
that it would be extremely difficult to
separate completely the biochemical
changes belonging to the toxic manifesta-
tions from those peculiar to the carcino-
genic events. Indeed, it is feasible that
the toxic and carcinogenic properties of
DCE may be attributable to the same
reactive metabolites, viz. 1,1-dichloro-
ethylene oxide and chloroacetyl chloride
(v. supra). But any concept of tumours
arising only in the wake of extensive
tissue injury and healing processes appears
at first to be incompatible with an associa-
tionbetweenneoplastic changeandspecific
modification of nucleic acids, particularly
of DNA. However, there is evidence that
continuous cell injury must play some role
in carcinogenesis, for example, the link
betweenalcoholconsumption, cirrhosisand
liver cancer in man or the sorts of experi-
ment showing that cells which are forced
to replicate, such as after partial hepatec-
tomy, are more sensitive than non-pro-
liferating cells. In addition, the fact may
be mentioned that some attested carcino-
genic agents evince other toxic properties,
including the long-standing "solar" derma-
titis that is associated with skin cancer
incurred by u.v. light (Berenblum, 1974)
and the hyperplasia and other early
benign signs that accompany bladder
cancer induced by aromatic amines
(Clayson, 1962, 1974). Thus, there appears
to be more evidence in favour of a link
between toxicity and carcinogenesis than
there is against it.
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